In cancer of the breast, liver and colon, activin signals were found to inhibit tumor cell growth and tumor tissue expressed decreased levels of ActA, increased levels of activin antagonists or demonstrated a loss of functional activin receptors or SMAD proteins [24-27]. Here, INHBE is linked to cancer.